The US blockade against Cuba has a particularly strong impact on the development of biotechnology and the local pharmaceutical industry, the island’s mission to the United Nations highlighted today.
At the same time that these areas are confirmed as pillars of national sovereignty, Washington’s economic, commercial and financial siege hinders their progress, the Cuban legation indicated in a press release.
“Such repercussions are evident in the BioCubaFarma business group, responsible for the production of medicines, equipment and high-tech services for the improvement of human health, the generation of goods and services for export and the production of food with state-of-the-art technology. ”
The effect of the blockade on the island’s biotechnological and pharmaceutical industry not only affects Cubans, it also deprives Americans, among others, of receiving the benefits of biotechnological and pharmaceutical products developed in the Caribbean country, the text states.
In this regard, he referred to internationally recognized Cuban medicines, such as HEBERPROT-P, GAVAC or Proctokinase, which cannot be exported to the United States due to the restrictions imposed by the economic, commercial and financial siege.
According to the Cuban mission to the UN, the impossibility of entering these products into the North American market caused the Center for Genetic Engineering and Biotechnology to lose millions of dollars related to income due to the non-export of goods and services.
